| Trial ID: | L2573 |
| Source ID: | NCT01097681
|
| Associated Drug: |
Asp1941
|
| Title: |
A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: ASP1941
|
| Outcome Measures: |
Primary: Plasma concentration of ASP1941, For 72 hours after dosing | Secondary: Urinary levels of ASP1941, For 72 hours after dosing|Urinary glucose excretion, For 72 hours after dosing|Safety assessed by adverse events, vital signs, laboratory tests and 12-lead ECGs, For 72 hours after dosing
|
| Sponsor/Collaborators: |
Sponsor: Astellas Pharma Inc
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
|
| Start Date: |
2010-02-16
|
| Completion Date: |
2010-06-18
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-12
|
| Locations: |
Kansai, Japan|Kantou, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01097681
|
